CDNATL 2017: Programme
Saturday 8th - Sunday 9th April 2017
The University of Cape Town, Cape Town, South Africa
Chairpersons & Scientific Committee:
Professor Derek Yellon, Professor Sir John Cunningham, Professor Brian Rayner, Professor Mpiko Ntsekhe,
Dr Peter Libby, Dr Marc Pfeffer, Dr Richard Horton, Professor Lionel Opie, & Professor Karen Sliwa
Professor Derek Yellon, Professor Sir John Cunningham, Professor Brian Rayner, Professor Mpiko Ntsekhe,
Dr Peter Libby, Dr Marc Pfeffer, Dr Richard Horton, Professor Lionel Opie, & Professor Karen Sliwa
Please click here for a printable PDF version of this programme.
Please note that timings are provisional and subject to change.
Speaker Conflict of Interest forms are here
Confirmation of accreditation is here
Saturday morning
09.00
09.15
The Lancet Lecture:
Novel concepts of the pathogenesis of the acute coronary syndromes.
Harvard Medical School, Boston, USA
10.00
Cardio-Oncology – preventing the cancer patient of today being the heart failure patient of tomorrow!
Vanderbilt University Medical Center, Nashville, USA
10.40
Break
11.10
What is the connection between the heart and the brain?
Tel Aviv Medical Centre, Israel
11.50
PCI vs CABG for multi-vessel and left main coronary disease – do we have the evidence?
Mayo Clinic College of Medicine, Rochester, USA
12.30
Lunch
Saturday afternoon
13.30
The Hatter Award Lecture:
Is it time to look at microvascular angina? Are these the new limits?
Cedars-Sinai Heart Institute, California, USA
14.10
SGLT2 inhibition – a novel strategy to improve type 2 diabetes, cardiovascular & renal outcome
University Hospital, Liverpool, UK
14.50
Trials and tribulations in AKI. Do we know where we are going?
VA Pittsburgh Healthcare System, USA
15.30
Break
16.00
The preconditioning phenomenon – lost in translation?
University of Essen, Germany
16.40
The NIHR-UCLH Biomedical Research Centre Lecture:
Diabetes & the kidney: BP control-how low can you go?
University College London, UK
17:20
Close
Saturday evening
19:00
Pre-dinner talk:
Are there limits to global engagement?
UK High Commission to South Africa (2009 – 2013) Vice Provost – International, University College London, UK
Sunday morning
09:40
The SA Heart & British Cardiovascular Society Lecture:
The prevention, management and control of rheumatic heart disease: are we at the limits?
University of Cape Town, South Africa
10:20
Break
10:50
eGFR & CKD Staging. Better understanding or a struggle with the law of unintended consequences?
University of Oxford, UK
11:30
GLP-1 analogues & DPPIV Inhibitors – are there new limits for beneficial cardiovascular outcome in type 2 diabetes?
Joslin Diabetes Centre, Boston, USA
12:10
Lunch
Sunday afternoon
13:10
PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?
Imperial College, London, UK
13:50
v 
Debate: Strategies for optimising haemoglobin in CKD (both pre and post dialysis) & CV Disease. What level and how to get there?
Kings College, London, UK
Against: Dr Marc Pfeffer
Harvard University, Boston, USA
14:50
Summary
15:00
Close